Skip to main content
PMC home page
The BMJ logoLink to The BMJ
. 1991 Jun 15;302(6790):1428–1431. doi: 10.1136/bmj.302.6790.1428

Cerebrovascular events after myocardial infarction: analysis of the GISSI trial. Gruppo Italiano per lo Studio della Streptochinasi nell'Infarto Miocardico (GISSI).

A P Maggioni 1, M G Franzosi 1, M L Farina 1, E Santoro 1, M G Celani 1, S Ricci 1, G Tognoni 1
PMCID: PMC1670110  PMID: 2070108

Abstract

OBJECTIVES--To describe the epidemiology of cerebrovascular events in patients given or not given fibrinolytic treatment and to assess the prognostic implications and risk factors. DESIGN--Case series derived from the GISSI randomised trial. SETTING--176 coronary care units in Italy giving various levels of care. PATIENTS--5860 patients with acute myocardial infarction treated with 1.5 million units of intravenous streptokinase and 5852 patients not given fibrinolytic treatment. MAIN OUTCOME MEASURES--Cerebrovascular event, sex, age, blood pressure, history of previous infarct, site of infarction, and Killip class. RESULTS--99 of 11,712 patients (0.84%) had a cerebrovascular event. Older age, worse Killip class, and anterior location of infarction seemed to be risk factors for cerebrovascular events (40/3201 aged 65-75 v 42/7295 aged less than 65, odds ratio 2.18; 9/437 class 3 v 55/8277 class 1, 1.81; and 57/4878 anterior v 24/4013 posterior, 1.96). No significant difference was found in the rate of cerebrovascular events between patients treated with streptokinase and controls (45/5852 (0.92%) streptokinase v 54/5860 (0.77) control). More patients in the streptokinase group than in the control group had cerebrovascular events (especially haemorrhagic strokes) on day 0-1 after randomisation (27 streptokinase v 7, control), although this was balanced by late events in control patients (54 streptokinase v 45 control at one year). The mortality of patients who had a cerebrovascular event was higher than that of those who did not (47% (47/99) v 11.6% (1350/11,613]. CONCLUSIONS--Although the incidence of cerebrovascular events complicating myocardial infarction was low, they increased morbidity and mortality. Treatment with streptokinase did not significantly alter the incidence, but age and poor haemodynamic state were associated with an increased risk.

Full text

PDF
1428

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Asinger R. W., Mikell F. L., Elsperger J., Hodges M. Incidence of left-ventricular thrombosis after acute transmural myocardial infarction. Serial evaluation by two-dimensional echocardiography. N Engl J Med. 1981 Aug 6;305(6):297–302. doi: 10.1056/NEJM198108063050601. [DOI] [PubMed] [Google Scholar]
  2. Beevers D. G., Erskine E., Robertson M., Beattie A. D., Campbell B. C., Goldberg A., Moore M. R., Hawthorne V. M. Blood-lead and hypertension. Lancet. 1976 Jul 3;2(7975):1–3. [PubMed] [Google Scholar]
  3. Chin P. L., Kaminski J., Rout M. Myocardial infarction coincident with cerebrovascular accidents in the elderly. Age Ageing. 1977 Feb;6(1):29–37. doi: 10.1093/ageing/6.1.29. [DOI] [PubMed] [Google Scholar]
  4. Dimant J., Grob D. Electrocardiographic changes and myocardial damage in patients with acute cerebrovascular accidents. Stroke. 1977 Jul-Aug;8(4):448–455. doi: 10.1161/01.str.8.4.448. [DOI] [PubMed] [Google Scholar]
  5. Grines C. L., DeMaria A. N. Optimal utilization of thrombolytic therapy for acute myocardial infarction: concepts and controversies. J Am Coll Cardiol. 1990 Jul;16(1):223–231. doi: 10.1016/0735-1097(90)90482-5. [DOI] [PubMed] [Google Scholar]
  6. Johannessen K. A., Nordrehaug J. E., von der Lippe G., Vollset S. E. Risk factors for embolisation in patients with left ventricular thrombi and acute myocardial infarction. Br Heart J. 1988 Aug;60(2):104–110. doi: 10.1136/hrt.60.2.104. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Komrad M. S., Coffey C. E., Coffey K. S., McKinnis R., Massey E. W., Califf R. M. Myocardial infarction and stroke. Neurology. 1984 Nov;34(11):1403–1409. doi: 10.1212/wnl.34.11.1403. [DOI] [PubMed] [Google Scholar]
  8. McAllen P. M., Marshall J. Cerebrovascular incidents after myocardial infarction. J Neurol Neurosurg Psychiatry. 1977 Oct;40(10):951–955. doi: 10.1136/jnnp.40.10.951. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. O'Connor C. M., Califf R. M., Massey E. W., Mark D. B., Kereiakes D. J., Candela R. J., Abbottsmith C., George B., Stack R. S., Aronson L. Stroke and acute myocardial infarction in the thrombolytic era: clinical correlates and long-term prognosis. J Am Coll Cardiol. 1990 Sep;16(3):533–540. doi: 10.1016/0735-1097(90)90338-p. [DOI] [PubMed] [Google Scholar]
  10. Puletti M., Morocutti C., Tronca M., Fattapposta F., Borgia C., Curione M., Cusmano E. Cerebrovascular accidents in acute myocardial infarction. Ital J Neurol Sci. 1987 Jun;8(3):245–248. doi: 10.1007/BF02337481. [DOI] [PubMed] [Google Scholar]
  11. Thompson P. L., Robinson J. S. Stroke after acute myocardial infarction: relation to infarct size. Br Med J. 1978 Aug 12;2(6135):457–459. doi: 10.1136/bmj.2.6135.457. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Turpie A. G., Robinson J. G., Doyle D. J., Mulji A. S., Mishkel G. J., Sealey B. J., Cairns J. A., Skingley L., Hirsh J., Gent M. Comparison of high-dose with low-dose subcutaneous heparin to prevent left ventricular mural thrombosis in patients with acute transmural anterior myocardial infarction. N Engl J Med. 1989 Feb 9;320(6):352–357. doi: 10.1056/NEJM198902093200604. [DOI] [PubMed] [Google Scholar]
  13. Weinreich D. J., Burke J. F., Pauletto F. J. Left ventricular mural thrombi complicating acute myocardial infarction. Long-term follow-up with serial echocardiography. Ann Intern Med. 1984 Jun;100(6):789–794. doi: 10.7326/0003-4819-100-6-789. [DOI] [PubMed] [Google Scholar]
  14. Yusuf S., Collins R., Peto R., Furberg C., Stampfer M. J., Goldhaber S. Z., Hennekens C. H. Intravenous and intracoronary fibrinolytic therapy in acute myocardial infarction: overview of results on mortality, reinfarction and side-effects from 33 randomized controlled trials. Eur Heart J. 1985 Jul;6(7):556–585. doi: 10.1093/oxfordjournals.eurheartj.a061905. [DOI] [PubMed] [Google Scholar]

Articles from BMJ : British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES